9315593

Source:http://linkedlifedata.com/resource/pubmed/id/9315593

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0004147, umls-concept:C0030705, umls-concept:C0206064, umls-concept:C0332624, umls-concept:C0429028, umls-concept:C0524620, umls-concept:C1280500
pubmed:issue	6
pubmed:dateCreated	1997-10-21
pubmed:abstractText	Atenolol reduces QT dispersion and corrected QT interval in patients with syndrome X. This suggests that symptomatic improvement induced by atenolol in syndrome X patients may be partly related to reduction in abnormally augmented sympathetic tone.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0207277
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Adrenergic beta-Antagonists, http://linkedlifedata.com/resource/pubmed/chemical/Atenolol
pubmed:status	MEDLINE
pubmed:month	Sep
pubmed:issn	0002-9149
pubmed:author	pubmed-author:ChierchiaS LSL, pubmed-author:FragassoGG, pubmed-author:LeonardoFF, pubmed-author:PagnottaPP, pubmed-author:RosanoG MGM
pubmed:issnType	Print
pubmed:day	15
pubmed:volume	80
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	789-90
pubmed:dateRevised	2004-11-17
pubmed:meshHeading	pubmed-meshheading:9315593-Adrenergic beta-Antagonists, pubmed-meshheading:9315593-Atenolol, pubmed-meshheading:9315593-Electrocardiography, pubmed-meshheading:9315593-Female, pubmed-meshheading:9315593-Humans, pubmed-meshheading:9315593-Male, pubmed-meshheading:9315593-Microvascular Angina, pubmed-meshheading:9315593-Middle Aged
pubmed:year	1997
pubmed:articleTitle	Effect of atenolol on QT interval and dispersion in patients with syndrome X.
pubmed:affiliation	Department of Cardiology, Istituto H San Raffaele, Milano-Roma, Roma, Italy.
pubmed:publicationType	Journal Article, Clinical Trial, Controlled Clinical Trial